F. Villejuif, 6 German Institute of Human Nutrition Potsdam-Rehbruecke Department of Epidemiology Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 7 WHO Collaborating Center for Food and Nutrition Policies, pp.75-115

H. Avenue and . Boston, 10 Bureau of Epidemiologic Research, Academy of Athens, Panepistimiou Street, vol.28, pp.106-79

M. P. Arezzo, 12 Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 13 Department of Clinical and Experimental Medicine, Federico II University 14 Cancer Registry and Histopathology Unit 17 Public Health and Health Planning Directorate, Asturias, Spain. 18 Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Greece. 11 Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute ? ISPO 16 HuGeF Foundation Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), p.20, 1921.

B. Weigelt and J. Reis-filho, Histological and molecular types of breast cancer: is there a unifying taxonomy?, Nature Reviews Clinical Oncology, vol.16, issue.12, pp.718-730, 2009.
DOI : 10.1038/nrclinonc.2009.166

M. Althuis, J. Fergenbaum, M. Garcia-closas, L. Brinton, M. Madigan et al., Etiology of hormone receptor-defined breast cancer: a systematic review of the literature, Cancer Epidemiol Biomarkers Prev, issue.10, pp.131558-1568, 2004.

H. Ma, L. Bernstein, M. Pike, and G. Ursin, Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies, Breast Cancer Research, vol.15, issue.4, p.43, 2006.
DOI : 10.1016/j.tem.2004.05.011

E. Rakha, M. Sayed, A. Green, E. Paish, D. Powe et al., Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor???Positive Phenotype, Journal of Clinical Oncology, vol.25, issue.30, pp.254772-4778, 2007.
DOI : 10.1200/JCO.2007.12.2747

F. Geyer and J. Reis-filho, Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet?, International Journal of Surgical Pathology, vol.17, issue.4, pp.285-302, 2008.
DOI : 10.1177/1066896908328577

P. Wirapati, C. Sotiriou, S. Kunkel, P. Farmer, S. Pradervand et al., Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures, Breast Cancer Research, vol.6, issue.4, p.65, 2008.
DOI : 10.1038/nrc1802

C. Perou, T. Sorlie, M. Eisen, R. V. De, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, issue.6797, pp.406747-752, 2000.

R. Tamimi, H. Baer, J. Marotti, M. Galan, L. Galaburda et al., Comparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer, Breast Cancer Research, vol.275, issue.4, p.67, 2008.
DOI : 10.1001/jama.1996.03530360023033

S. Lord, L. Bernstein, K. Johnson, K. Malone, J. Mcdonald et al., Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control Study, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.7, pp.171723-1730, 2008.
DOI : 10.1158/1055-9965.EPI-07-2824

X. Yang, J. Chang-claude, E. Goode, F. Couch, H. Nevanlinna et al., Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies, JNCI Journal of the National Cancer Institute, vol.103, issue.3, pp.250-263, 2011.
DOI : 10.1093/jnci/djq526

R. Millikan, B. Newman, C. Tse, P. Moorman, K. Conway et al., Epidemiology of basal-like breast cancer, Breast Cancer Research and Treatment, vol.315, issue.1 Suppl, pp.123-139, 2008.
DOI : 10.1007/s10549-007-9632-6

G. Gierach, A. Burke, and W. Anderson, Epidemiology of triple negative breast cancers, Breast Disease, vol.32, issue.1-2, pp.5-24, 2010.
DOI : 10.3233/BD-2010-0319

Y. Yasui and J. Potter, The shape of age-incidence curves of female breast cancer by hormone-receptor status, Cancer Causes and Control, vol.10, issue.5, pp.431-437, 1999.
DOI : 10.1023/A:1008970121595

A. Phipps, R. Chlebowski, R. Prentice, A. Mctiernan, J. Wactawski-wende et al., Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer, JNCI Journal of the National Cancer Institute, vol.103, issue.6, pp.470-477, 2011.
DOI : 10.1093/jnci/djr030

A. Phipps, K. Malone, P. Porter, J. Daling, and C. Li, Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer, Cancer, vol.109, issue.7, pp.1521-1526, 2008.
DOI : 10.1002/cncr.23786

E. Riboli and R. Kaaks, The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition, International Journal of Epidemiology, vol.26, issue.90001, pp.6-14, 1997.
DOI : 10.1093/ije/26.suppl_1.S6

E. Riboli, K. Hunt, N. Slimani, P. Ferrari, T. Norat et al., European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection, European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection, pp.1113-1124, 2002.
DOI : 10.1093/ije/26.suppl_1.S1

N. Onland-moret, P. Peeters, C. Van-gils, F. Clavel-chapelon, T. Key et al., Age at Menarche in Relation to Adult Height: The EPIC Study, American Journal of Epidemiology, vol.162, issue.7, pp.162623-632, 2005.
DOI : 10.1093/aje/kwi260

M. Haftenberger, P. Lahmann, S. Panico, C. Gonzalez, J. Seidell et al., Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) Public Health Nutr, pp.1147-1162, 2002.

V. Krogh, S. Panico, R. Tumino, C. Sacerdote, L. Rodriguez et al., Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case?control study, Cancer Prev Res, vol.4, issue.10, pp.1626-1635, 2011.

N. Wareham, R. Jakes, K. Rennie, J. Schuit, J. Mitchell et al., Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, Public Health Nutrition, vol.35, issue.04, pp.407-413, 2003.
DOI : 10.1093/ije/26.suppl_1.S181

I. Heuch, G. Albrektsen, and G. Kvale, Modeling Effects of Age at and Time Since Delivery on Subsequent Risk of Cancer, Epidemiology, vol.10, issue.6, pp.739-746, 1999.
DOI : 10.1097/00001648-199911000-00015

M. Lunn and D. Mcneil, Applying Cox Regression to Competing Risks, Biometrics, vol.51, issue.2, pp.524-532, 1995.
DOI : 10.2307/2532940

R. Ritte, A. Lukanova, F. Berrino, L. Dossus, A. Tjonneland et al., Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study, Breast Cancer Research, vol.20, issue.Suppl 1, p.76
DOI : 10.1093/annonc/mdp322

URL : https://hal.archives-ouvertes.fr/inserm-00704067

V. Setiawan, K. Monroe, L. Wilkens, L. Kolonel, M. Pike et al., Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status: The Multiethnic Cohort Study, American Journal of Epidemiology, vol.169, issue.10, pp.1691251-1259, 2009.
DOI : 10.1093/aje/kwp036

S. Hankinson, R. Tamimi, D. Hunter, D. Hunter, and T. D. Oxford, Breast cancer In Textbook of Cancer Epidemiology, pp.403-445

R. Ritte, A. Lukanova, A. Tjonneland, A. Olsen, K. Overvad et al., al: Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study

D. Apter, M. Reinila, and R. Vihko, Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood, International Journal of Cancer, vol.9, issue.5
DOI : 10.1002/ijc.2910440506

M. Dietel, M. Lewis, and S. Shapiro, Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review, Human Reproduction, vol.20, issue.8, pp.2052-2060, 2005.
DOI : 10.1093/humrep/dei043

D. Allred, P. Brown, and D. Medina, The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer, Breast Cancer Research, vol.6, issue.6, pp.240-245, 2004.
DOI : 10.1023/A:1011308707512

M. Asselin-labat, F. Vaillant, J. Sheridan, B. Pal, D. Wu et al., Control of mammary stem cell function by steroid hormone signalling, Nature, vol.21, issue.7299, pp.465798-802, 2010.
DOI : 10.1038/nature09027

I. Russo and J. Russo, Pregnancy-Induced Changes in Breast Cancer Risk, Journal of Mammary Gland Biology and Neoplasia, vol.30, issue.3, pp.221-233, 2011.
DOI : 10.1007/s10911-011-9228-y

H. Ma, L. Bernstein, R. Ross, and G. Ursin, Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case???control and a case???case comparison, Breast Cancer Research, vol.15, issue.4, p.39, 2006.
DOI : 10.1016/j.tem.2004.05.011

J. Dolle, J. Daling, E. White, L. Brinton, D. Doody et al., Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.4, pp.1157-1166, 2009.
DOI : 10.1158/1055-9965.EPI-08-1005

M. Althuis, D. Brogan, R. Coates, J. Daling, M. Gammon et al., Breast cancers among very young premenopausal women (United States) Cancer Causes Control, pp.151-160, 2003.

C. Sweeney, A. Giuliano, K. Baumgartner, T. Byers, J. Herrick et al., Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women, International Journal of Cancer, vol.106, issue.11
DOI : 10.1002/ijc.22970

L. Rosenberg, D. Boggs, L. Wise, L. Adams-campbell, and J. Palmer, Oral Contraceptive Use and Estrogen/Progesterone Receptor-Negative Breast Cancer among African American Women, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.8, pp.2073-2079, 2010.
DOI : 10.1158/1055-9965.EPI-10-0428

N. Magne, R. Toillon, P. Castadot, A. Ramaioli, and M. Namer, Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years, Breast Cancer Research and Treatment, vol.117, issue.5, pp.95179-184, 2006.
DOI : 10.1007/s10549-005-9065-z

G. Chebil, P. Bendahl, I. Idvall, and M. Ferno, Comparison of Immunohistochemical and Biochemical Assay of Steroid Receptors in Primary Breast Cancer Clinical Associations and Reasons for Discrepancies, Acta Oncologica, vol.14, issue.7, pp.719-725, 2003.
DOI : 10.1038/bjc.1996.291

A. Welsh, C. Moeder, S. Kumar, P. Gershkovich, E. Alarid et al., Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive Cells, Journal of Clinical Oncology, vol.29, issue.22, pp.292978-2984, 2011.
DOI : 10.1200/JCO.2010.32.9706

K. Hede, Breast Cancer Testing Scandal Shines Spotlight on Black Box of Clinical Laboratory Testing, JNCI Journal of the National Cancer Institute, vol.100, issue.12, pp.836-837, 2008.
DOI : 10.1093/jnci/djn200

K. Chu, W. Anderson, A. Fritz, L. Ries, and O. Brawley, Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups, Cancer, vol.53, issue.Suppl, pp.37-45, 2001.
DOI : 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F